LIST OF EXHIBITS
EXHIBIT 1 SEGMENTATION OF GLOBAL IMMUNOGLOBULINS MARKET
EXHIBIT 2 MARKET SIZE CALCULATION APPROACH 2020
EXHIBIT 3 IMPACT OF DEVELOPMENTS IN PLASMA FRACTIONATION PROCESS
EXHIBIT 4 IMPACT OF IMMUNOGLOBULINS IN HOMECARE
EXHIBIT 5 IMPACT OF RECENT REGULATORY APPROVALS FOR IMMUNOGLOBULIN
EXHIBIT 6 IMPACT OF USE OF IVIG DURING TRANSPLANT
EXHIBIT 7 SELF-SUFFICIENCY PROGRAMS FOR PLASMA-DERIVED MEDICINAL PRODUCTS
EXHIBIT 8 IMPACT OF IVIG-ASSOCIATED HEMOLYSIS
EXHIBIT 9 IMPACT OF SHORTAGE OF IMMUNOGLOBULIN PRODUCTS
EXHIBIT 10 GLOBAL IMMUNOGLOBULINS MARKET 2020–2026 ($ BILLION)
EXHIBIT 11 GLOBAL IMMUNOGLOBULINS MARKET BY PRODUCT TYPE
EXHIBIT 12 GLOBAL IMMUNOGLOBULINS MARKET BY APPLICATION
EXHIBIT 13 GLOBAL IMMUNOGLOBULINS MARKET BY END-USER
EXHIBIT 14 GLOBAL IMMUNOGLOBULINS MARKET BY GEOGRAPHY
EXHIBIT 15 FIVE FORCES ANALYSIS 2020
EXHIBIT 16 INCREMENTAL GROWTH BY PRODUCT TYPE 2020 & 2026
EXHIBIT 17 GLOBAL IMMUNOGLOBULINS MARKET BY PRODUCT TYPE
EXHIBIT 18 GLOBAL IMMUNOGLOBULINS MARKET BY PRODUCT TYPE: INCREMENTAL GROWTH 2020–2026 ($ BILLION)
EXHIBIT 19 GLOBAL IMMUNOGLOBULINS MARKET BY PRODUCT TYPE: ABSOLUTE GROWTH 2020–2026 (%)
EXHIBIT 20 GLOBAL INTRAVENOUS IMMUNOGLOBULINS MARKET: INCREMENTAL & ABSOLUTE GROWTH
EXHIBIT 21 GLOBAL INTRAVENOUS IMMUNOGLOBULINS MARKET 2020–2026 ($ BILLION)
EXHIBIT 22 INCREMENTAL GROWTH BY GEOGRAPHY 2020 & 2026
EXHIBIT 23 GLOBAL SUBCUTANEOUS IMMUNOGLOBULINS MARKET: INCREMENTAL & ABSOLUTE GROWTH
EXHIBIT 24 GLOBAL SUBCUTANEOUS IMMUNOGLOBULINS MARKET 2020–2026 ($ BILLION)
EXHIBIT 25 INCREMENTAL GROWTH BY GEOGRAPHY 2020 & 2026
EXHIBIT 26 GLOBAL INTRAMUSCULAR IMMUNOGLOBULINS MARKET: INCREMENTAL & ABSOLUTE GROWTH
EXHIBIT 27 GLOBAL INTRAMUSCULAR IMMUNOGLOBULINS MARKET 2020–2026 ($ BILLION)
EXHIBIT 28 INCREMENTAL GROWTH BY GEOGRAPHY 2020 & 2026
EXHIBIT 29 INCREMENTAL GROWTH BY SEGMENT 2020 & 2026
EXHIBIT 30 GLOBAL IMMUNOGLOBULINS MARKET BY APPLICATION
EXHIBIT 31 GLOBAL IMMUNOGLOBULINS MARKET BY APPLICATION: INCREMENTAL GROWTH 2020–2026 ($ BILLION)
EXHIBIT 32 GLOBAL IMMUNOGLOBULINS MARKET BY APPLICATION: ABSOLUTE GROWTH 2020–2026 ($ BILLION)
EXHIBIT 33 GLOBAL PRIMARY IMMUNODEFICIENCY MARKET: INCREMENTAL & ABSOLUTE GROWTH
EXHIBIT 34 GLOBAL PRIMARY IMMUNODEFICIENCY IMMUNOGLOBULINS MARKET 2020–2026 ($ BILLION)
EXHIBIT 35 INCREMENTAL GROWTH BY GEOGRAPHY 2020 & 2026
EXHIBIT 36 GLOBAL CIDP IMMUNOGLOBULINS MARKET: INCREMENTAL & ABSOLUTE GROWTH
EXHIBIT 37 GLOBAL CIDP IMMUNOGLOBULINS MARKET 2020–2026 ($ BILLION)
EXHIBIT 38 INCREMENTAL GROWTH BY GEOGRAPHY 2020 & 2026
EXHIBIT 39 GLOBAL SECONDARY IMMUNODEFICIENCY IMMUNOGLOBULINS MARKET: INCREMENTAL & ABSOLUTE GROWTH
EXHIBIT 40 GLOBAL SECONDARY IMMUNODEFICIENCY IMMUNOGLOBULINS MARKET 2020–2026 ($ BILLION)
EXHIBIT 41 INCREMENTAL GROWTH BY GEOGRAPHY 2020 & 2026
EXHIBIT 42 GLOBAL IMMUNE THROMBOCYTOPENIC PURPURA IMMUNOGLOBULINS MARKET: INCREMENTAL & ABSOLUTE GROWTH
EXHIBIT 43 GLOBAL IMMUNE THROMBOCYTOPENIC PURPURA IMMUNOGLOBULINS MARKET 2020–2026 ($ BILLION)
EXHIBIT 44 INCREMENTAL GROWTH BY GEOGRAPHY 2020 & 2026
EXHIBIT 45 GLOBAL MYASTHENIA GRAVIS IMMUNOGLOBULINS MARKET: INCREMENTAL GROWTH & ABSOLUTE GROWTH
EXHIBIT 46 GLOBAL MYASTHENIA GRAVIS IMMUNOGLOBULINS MARKET 2020–2026 ($ BILLION)
EXHIBIT 47 INCREMENTAL GROWTH BY GEOGRAPHY 2020 & 2026
EXHIBIT 48 GLOBAL IMMUNOGLOBULINS MARKET BY OTHERS: INCREMENTAL & ABSOLUTE GROWTH
EXHIBIT 49 GLOBAL OTHER IMMUNOGLOBULINS MARKET 2020–2026 ($ BILLION)
EXHIBIT 50 INCREMENTAL GROWTH BY GEOGRAPHY 2020 & 2026
EXHIBIT 51 INCREMENTAL GROWTH BY APPLICATION 2020 & 2026
EXHIBIT 52 GLOBAL IMMUNOGLOBULINS MARKET BY END-USER
EXHIBIT 53 GLOBAL IMMUNOGLOBULINS MARKET BY END-USER: INCREMENTAL GROWTH 2020–2026 ($ BILLION)
EXHIBIT 54 GLOBAL IMMUNOGLOBULINS MARKET BY END-USER: ABSOLUTE GROWTH 2020–2026 (%)
EXHIBIT 55 GLOBAL HOSPITALS & CLINICS IMMUNOGLOBULINS MARKET: INCREMENTAL & ABSOLUTE GROWTH
EXHIBIT 56 GLOBAL HOSPITALS & CLINICS IMMUNOGLOBULINS MARKET 2020–2026 ($ BILLION)
EXHIBIT 57 INCREMENTAL GROWTH BY GEOGRAPHY 2020 & 2026
EXHIBIT 58 GLOBAL HOMECARE IMMUNOGLOBULINS MARKET: INCREMENTAL & ABSOLUTE GROWTH
EXHIBIT 59 GLOBAL HOMECARE IMMUNOGLOBULINS MARKET 2020–2026 ($ BILLION)
EXHIBIT 60 INCREMENTAL GROWTH BY GEOGRAPHY 2020 & 2026
EXHIBIT 61 INCREMENTAL GROWTH BY GEOGRAPHY 2020 & 2026
EXHIBIT 62 GLOBAL IMMUNOGLOBULINS MARKET: KEY COUNTRIES
EXHIBIT 63 GLOBAL IMMUNOGLOBULINS MARKET BY GEOGRAPHY: INCREMENTAL GROWTH 2020–2026 ($ BILLION)
EXHIBIT 64 GLOBAL IMMUNOGLOBULINS MARKET BY GEOGRAPHY: ABSOLUTE GROWTH 2020–2026 (%)
EXHIBIT 65 NORTH AMERICA IMMUNOGLOBULINS MARKET: KEY COUNTRIES 2020 ($ BILLION)
EXHIBIT 66 NORTH AMERICA IMMUNOGLOBULINS MARKET 2020–2026 ($ BILLION)
EXHIBIT 67 INCREMENTAL GROWTH BY PRODUCT TYPE 2020 & 2026
EXHIBIT 68 INCREMENTAL GROWTH BY APPLICATION 2020 & 2026
EXHIBIT 69 INCREMENTAL GROWTH BY END-USER 2020 & 2026
EXHIBIT 70 INCREMENTAL GROWTH IN NORTH AMERICA 2020 & 2026
EXHIBIT 71 IMMUNOGLOBULINS MARKET IN US 2020–2026 ($ BILLION)
EXHIBIT 72 IMMUNOGLOBULINS MARKET IN CANADA 2020–2026 ($ BILLION)
EXHIBIT 73 EUROPE IMMUNOGLOBULINS MARKET: KEY COUNTRIES 2020 ($ BILLION)
EXHIBIT 74 EUROPE IMMUNOGLOBULINS MARKET 2020–2026 ($ BILLION)
EXHIBIT 75 INCREMENTAL GROWTH BY PRODUCT TYPE 2020 & 2026
EXHIBIT 76 INCREMENTAL GROWTH BY APPLICATION 2020 & 2026
EXHIBIT 77 INCREMENTAL GROWTH BY END-USER 2020 & 2026
EXHIBIT 78 INCREMENTAL GROWTH IN EUROPE 2020 & 2026
EXHIBIT 79 IMMUNOGLOBULINS MARKET IN GERMANY 2020–2026 ($ BILLION)
EXHIBIT 80 IMMUNOGLOBULINS MARKET IN FRANCE 2020–2026 ($ BILLION)
EXHIBIT 81 IMMUNOGLOBULINS MARKET IN UK 2020–2026 ($ BILLION)
EXHIBIT 82 IMMUNOGLOBULINS MARKET IN ITALY 2020–2026 ($ BILLION)
EXHIBIT 83 IMMUNOGLOBULINS MARKET IN SPAIN 2020–2026 ($ BILLION)
EXHIBIT 84 APAC IMMUNOGLOBULINS MARKET: KEY COUNTRIES 2020 ($ BILLION)
EXHIBIT 85 IMMUNOGLOBULINS MARKET IN APAC 2020–2026 ($ BILLION)
EXHIBIT 86 INCREMENTAL GROWTH BY PRODUCT TYPE 2020 & 2026
EXHIBIT 87 INCREMENTAL GROWTH BY APPLICATION 2020 & 2026
EXHIBIT 88 INCREMENTAL GROWTH BY END-USER 2020 & 2026
EXHIBIT 89 INCREMENTAL GROWTH IN APAC 2020 & 2026
EXHIBIT 90 IMMUNOGLOBULINS MARKET IN CHINA 2020–2026 ($ BILLION)
EXHIBIT 91 IMMUNOGLOBULINS MARKET IN JAPAN 2020–2026 ($ BILLION)
EXHIBIT 92 IMMUNOGLOBULINS MARKET IN INDIA 2020–2026 ($ BILLION)
EXHIBIT 93 IMMUNOGLOBULINS MARKET IN AUSTRALIA 2020–2026 ($ BILLION)
EXHIBIT 94 IMMUNOGLOBULINS MARKET IN SOUTH KOREA 2020–2026 ($ BILLION)
EXHIBIT 95 LATIN AMERICA IMMUNOGLOBULINS MARKET: KEY COUNTRIES 2020 ($ BILLION)
EXHIBIT 96 LATIN AMERICA IMMUNOGLOBULINS MARKET 2020–2026 ($ BILLION)
EXHIBIT 97 INCREMENTAL GROWTH BY PRODUCT TYPE 2020 & 2026
EXHIBIT 98 INCREMENTAL GROWTH BY APPLICATION 2020 & 2026
EXHIBIT 99 INCREMENTAL GROWTH BY END-USER 2020 & 2026
EXHIBIT 100 INCREMENTAL GROWTH IN LATIN AMERICA 2020 & 2026
EXHIBIT 101 IMMUNOGLOBULINS MARKET IN BRAZIL 2020–2026 ($ BILLION)
EXHIBIT 102 IMMUNOGLOBULINS MARKET IN MEXICO 2020–2026 ($ BILLION)
EXHIBIT 103 IMMUNOGLOBULINS MARKET IN ARGENTINA 2020–2026 ($ BILLION)
EXHIBIT 104 MIDDLE EAST & AFRICA IMMUNOGLOBULINS MARKET: KEY COUNTRIES 2020 ($ BILLION)
EXHIBIT 105 MIDDLE EAST & AFRICA IMMUNOGLOBULINS MARKET 2020–2026 ($ BILLION)
EXHIBIT 106 INCREMENTAL GROWTH BY PRODUCT TYPE 2020 & 2026
EXHIBIT 107 INCREMENTAL GROWTH BY APPLICATION 2020 & 2026
EXHIBIT 108 INCREMENTAL GROWTH BY END-USER 2020 & 2026
EXHIBIT 109 INCREMENTAL GROWTH IN MIDDLE EAST & AFRICA 2020 & 2026
EXHIBIT 110 IMMUNOGLOBULINS MARKET IN SOUTH AFRICA 2020–2026 ($ BILLION)
EXHIBIT 111 IMMUNOGLOBULINS MARKET IN SAUDI ARABIA 2020–2026 ($ BILLION)
EXHIBIT 112 IMMUNOGLOBULINS MARKET IN TURKEY 2020–2026 ($ BILLION)
EXHIBIT 113 GLOBAL IMMUNOGLOBULINS MARKET: VENDOR MARKET SHARE (2020)
EXHIBIT 114 TAKEDA PHARMACEUTICAL COMPANY LIMITED: TOTAL REVENUE 2018−2020 ($ BILLION)
EXHIBIT 115 TAKEDA PHARMACEUTICAL COMPANY LIMITED: TOTAL REVENUE BY GEOGRAPHY 2019 & 2020 ($ BILLION)
EXHIBIT 116 TAKEDA PHARMACEUTICAL COMPANY LIMITED: R&D EXPENDITURE 2018−2020 ($ BILLION)
EXHIBIT 117 TAKEDA PHARMACEUTICAL COMPANY LIMITED: TOTAL REVENUE BY IMMUNOGLOBIN 2018−2020 ($ BILLION)
EXHIBIT 118 CSL LIMITED: TOTAL REVENUE 2018−2020 ($ MILLION)
EXHIBIT 119 CSL LIMITED: R&D EXPENDITURE 2018−2020 ($ MILLION)
EXHIBIT 120 GRIFOLS, S.A.: TOTAL REVENUE 2018−2020 ($ MILLION)
EXHIBIT 121 GRIFOLS, S.A.: R&D EXPENDITURE 2018−2020 ($ MILLION)
EXHIBIT 122 KENDRION: TOTAL REVENUE 2018−2020 ($ MILLION)
EXHIBIT 123 KENDRION: R&D EXPENDITURE 2018−2020 ($ MILLION)
EXHIBIT 124 OCTAPHARMA AG: TOTAL REVENUE 2018−2020 ($ MILLION)
EXHIBIT 125 OCTAPHARMA AG: R&D EXPENDITURE 2018−2020 ($ MILLION)
LIST OF TABLES
TABLE 1 KEY CAVEATS
TABLE 2 CURRENCY CONVERSION 2013−2020
TABLE 3 NORTH AMERICA IMMUNOGLOBULINS MARKET BY PRODUCT TYPE 2020–2026 ($ BILLION)
TABLE 4 NORTH AMERICA IMMUNOGLOBULINS MARKET BY PRODUCT TYPE 2020–2026 (%)
TABLE 5 NORTH AMERICA IMMUNOGLOBULINS MARKET BY APPLICATION 2020–2026 ($ BILLION)
TABLE 6 NORTH AMERICA IMMUNOGLOBULINS MARKET BY APPLICATION 2020–2026 (%)
TABLE 7 NORTH AMERICA IMMUNOGLOBULINS MARKET BY END-USER 2020–2026 ($ BILLION)
TABLE 8 NORTH AMERICA IMMUNOGLOBULINS MARKET BY END-USER 2020–2026 (%)
TABLE 9 EUROPE IMMUNOGLOBULINS MARKET BY PRODUCT TYPE 2020–2026 ($ BILLION)
TABLE 10 EUROPE IMMUNOGLOBULINS MARKET BY PRODUCT TYPE 2020–2026 (%)
TABLE 11 EUROPE IMMUNOGLOBULINS MARKET BY APPLICATION 2020–2026 ($ BILLION)
TABLE 12 EUROPE IMMUNOGLOBULINS MARKET BY APPLICATION 2020–2026 (%)
TABLE 13 EUROPE IMMUNOGLOBULINS MARKET BY END-USER 2020–2026 ($ BILLION)
TABLE 14 EUROPE IMMUNOGLOBULINS MARKET BY END-USER 2020–2026 (%)
TABLE 15 APAC IMMUNOGLOBULINS MARKET BY PRODUCT TYPE 2020–2026 ($ BILLION)
TABLE 16 APAC IMMUNOGLOBULINS MARKET BY PRODUCT TYPE 2020–2026 (%)
TABLE 17 APAC IMMUNOGLOBULINS MARKET BY APPLICATION 2020–2026 ($ BILLION)
TABLE 18 APAC IMMUNOGLOBULINS MARKET BY APPLICATION 2020–2026 (%)
TABLE 19 APAC IMMUNOGLOBULINS MARKET BY END-USER 2020–2026 ($ BILLION)
TABLE 20 APAC IMMUNOGLOBULINS MARKET BY END-USER 2020–2026 (%)
TABLE 21 LATIN AMERICA IMMUNOGLOBULINS MARKET BY PRODUCT TYPE 2020–2026 ($ BILLION)
TABLE 22 LATIN AMERICA IMMUNOGLOBULINS MARKET BY PRODUCT TYPE 2020–2026 (%)
TABLE 23 LATIN AMERICA IMMUNOGLOBULINS MARKET BY APPLICATION 2020–2026 ($ BILLION)
TABLE 24 LATIN AMERICA IMMUNOGLOBULINS MARKET BY APPLICATION 2020–2026 (%)
TABLE 25 LATIN AMERICA IMMUNOGLOBULINS MARKET BY END-USER 2020–2026 ($ BILLION)
TABLE 26 LATIN AMERICA IMMUNOGLOBULINS MARKET BY END-USER 2020–2026 (%)
TABLE 27 MIDDLE EAST & AFRICA IMMUNOGLOBULINS MARKET BY PRODUCT TYPE 2020–2026 ($ BILLION)
TABLE 28 MIDDLE EAST & AFRICA IMMUNOGLOBULINS MARKET BY PRODUCT TYPE 2020–2026 (%)
TABLE 29 MIDDLE EAST & AFRICA IMMUNOGLOBULINS MARKET BY APPLICATION 2020–2026 ($ BILLION)
TABLE 30 MIDDLE EAST & AFRICA IMMUNOGLOBULINS MARKET BY APPLICATION 2020–2026 (%)
TABLE 31 MIDDLE EAST & AFRICA IMMUNOGLOBULINS MARKET BY END-USER 2020–2026 ($ BILLION)
TABLE 32 MIDDLE EAST & AFRICA IMMUNOGLOBULINS MARKET BY END-USER 2020–2026 (%)
TABLE 33 TAKEDA PHARMACEUTICAL COMPANY LIMITED: MAJOR PRODUCT OFFERINGS
TABLE 34 CSL: MAJOR PRODUCT OFFERINGS
TABLE 35 GRIFOLS, S.A.: MAJOR PRODUCT OFFERINGS
TABLE 36 KENDRION: MAJOR PRODUCT OFFERINGS
TABLE 37 OCTAPHARMA: MAJOR PRODUCT OFFERINGS
TABLE 38 CHINA BIOLOGIC PRODUCTS HOLDINGS, INC.: MAJOR PRODUCT OFFERINGS
TABLE 39 BIOTEST AG: MAJOR PRODUCT OFFERINGS
TABLE 40 LFB S.A.: MAJOR PRODUCT OFFERINGS
TABLE 41 ADMA BIOLOGICS, INC.: MAJOR PRODUCT OFFERINGS
TABLE 42 OMRIX BIOPHARMACEUTICALS LTD: MAJOR PRODUCT OFFERINGS
TABLE 43 ZYDUS CADILA: MAJOR PRODUCT OFFERINGS
TABLE 44 BHARAT SERUMS AND VACCINES LIMITED: MAJOR PRODUCT OFFERINGS
TABLE 45 RELIANCE LIFE SCIENCES: MAJOR PRODUCT OFFERINGS
TABLE 46 GLOBAL IMMUNOGLOBULINS MARKET BY PRODUCT TYPE 2020–2026 ($ BILLION)
TABLE 47 GLOBAL IMMUNOGLOBULINS MARKET BY PRODUCT TYPE 2020–2026 (%)
TABLE 48 NORTH AMERICA IMMUNOGLOBULINS MARKET BY PRODUCT TYPE 2020–2026 ($ BILLION)
TABLE 49 NORTH AMERICA IMMUNOGLOBULINS MARKET BY PRODUCT TYPE 2020–2026 (%)
TABLE 50 EUROPE IMMUNOGLOBULINS MARKET BY PRODUCT TYPE 2020–2026 ($ BILLION)
TABLE 51 EUROPE IMMUNOGLOBULINS MARKET BY PRODUCT TYPE 2020–2026 (%)
TABLE 52 APAC IMMUNOGLOBULINS MARKET BY PRODUCT TYPE 2020–2026 ($ BILLION)
TABLE 53 APAC IMMUNOGLOBULINS MARKET BY PRODUCT TYPE 2020–2026 (%)
TABLE 54 LATIN AMERICA IMMUNOGLOBULINS MARKET BY PRODUCT TYPE 2020–2026 ($ BILLION)
TABLE 55 LATIN AMERICA IMMUNOGLOBULINS MARKET BY PRODUCT TYPE 2020–2026 (%)
TABLE 56 MIDDLE EAST & AFRICA IMMUNOGLOBULINS MARKET BY PRODUCT TYPE 2020–2026 ($ BILLION)
TABLE 57 MIDDLE EAST & AFRICA IMMUNOGLOBULINS MARKET BY PRODUCT TYPE 2020–2026 (%)
TABLE 58 GLOBAL IMMUNOGLOBULINS MARKET BY APPLICATION 2020–2026 ($ BILLION)
TABLE 59 GLOBAL IMMUNOGLOBULINS MARKET BY APPLICATION 2020–2026 (%)
TABLE 60 NORTH AMERICA IMMUNOGLOBULINS MARKET BY APPLICATION 2020–2026 ($ BILLION)
TABLE 61 NORTH AMERICA IMMUNOGLOBULINS MARKET BY APPLICATION 2020–2026 (%)
TABLE 62 EUROPE IMMUNOGLOBULINS MARKET BY APPLICATION 2020–2026 ($ BILLION)
TABLE 63 EUROPE IMMUNOGLOBULINS MARKET BY APPLICATION 2020–2026 (%)
TABLE 64 APAC IMMUNOGLOBULINS MARKET BY APPLICATION 2020–2026 ($ BILLION)
TABLE 65 APAC IMMUNOGLOBULINS MARKET BY APPLICATION 2020–2026 (%)
TABLE 66 LATIN AMERICA IMMUNOGLOBULINS MARKET BY APPLICATION 2020–2026 ($ BILLION)
TABLE 67 LATIN AMERICA IMMUNOGLOBULINS MARKET BY APPLICATION 2020–2026 (%)
TABLE 68 MIDDLE EAST & AFRICA IMMUNOGLOBULINS MARKET BY APPLICATION 2020−2026 ($ BILLION)
TABLE 69 MIDDLE EAST & AFRICA IMMUNOGLOBULINS MARKET BY APPLICATION 2020−2026 (%)
TABLE 70 GLOBAL IMMUNOGLOBULINS MARKET BY END-USER 2020–2026 ($ BILLION)
TABLE 71 GLOBAL IMMUNOGLOBULINS MARKET BY END-USER 2020–2026 (%)
TABLE 72 NORTH AMERICA IMMUNOGLOBULINS MARKET BY END-USER 2020–2026 ($ BILLION)
TABLE 73 NORTH AMERICA IMMUNOGLOBULINS MARKET BY END-USER 2020−2026 (%)
TABLE 74 EUROPE IMMUNOGLOBULINS MARKET BY END-USER 2020–2026 ($ BILLION)
TABLE 75 EUROPE IMMUNOGLOBULINS MARKET BY END-USER 2020–2026 (%)
TABLE 76 APAC IMMUNOGLOBULINS MARKET BY END-USER 2020–2026 ($ BILLION)
TABLE 77 APAC IMMUNOGLOBULINS MARKET BY END-USER 2020–2026 (%)
TABLE 78 LATIN AMERICA IMMUNOGLOBULINS MARKET BY END-USER 2020–2026 ($ BILLION)
TABLE 79 LATIN AMERICA IMMUNOGLOBULINS MARKET BY END-USER 2020–2026 (%)
TABLE 80 MIDDLE EAST & AFRICA IMMUNOGLOBULINS MARKET BY END-USER 2020–2026 ($ BILLION)
TABLE 81 MIDDLE EAST & AFRICA IMMUNOGLOBULINS MARKET BY END-USER 2020–2026 (%)
TABLE 82 GLOBAL IMMUNOGLOBULINS MARKET BY GEOGRAPHY 2020–2026 ($ BILLION)
TABLE 83 GLOBAL IMMUNOGLOBULINS MARKET BY GEOGRAPHY 2020–2026 (%)
TABLE 84 GLOBAL INTRAVENOUS IMMUNOGLOBULINS MARKET 2020–2026 ($ BILLION)
TABLE 85 GLOBAL INTRAVENOUS IMMUNOGLOBULINS MARKET 2020–2026 (%)
TABLE 86 GLOBAL SUBCUTANEOUS IMMUNOGLOBULINS MARKET 2020–2026 ($ BILLION)
TABLE 87 GLOBAL SUBCUTANEOUS IMMUNOGLOBULINS MARKET 2020–2026 (%)
TABLE 88 GLOBAL INTRAMUSCULAR IMMUNOGLOBULINS MARKET 2020–2026 ($ BILLION)
TABLE 89 GLOBAL INTRAMUSCULAR IMMUNOGLOBULINS MARKET 2020–2026 (%)
TABLE 90 GLOBAL PRIMARY IMMUNODEFICIENCY IMMUNOGLOBULINS MARKET 2020–2026 ($ BILLION)
TABLE 91 GLOBAL PRIMARY IMMUNODEFICIENCY IMMUNOGLOBULINS MARKET 2020–2026 (%)
TABLE 92 GLOBAL CIDP IMMUNOGLOBULINS MARKET 2020–2026 ($ BILLION)
TABLE 93 GLOBAL CIDP IMMUNOGLOBULINS MARKET 2020–2026 (%)
TABLE 94 GLOBAL SECONDARY IMMUNODEFICIENCY IMMUNOGLOBULINS MARKET 2020–2026 ($ BILLION)
TABLE 95 GLOBAL SECONDARY IMMUNODEFICIENCY IMMUNOGLOBULINS MARKET 2020–2026 (%)
TABLE 96 GLOBAL IMMUNE THROMBOCYTOPENIC PURPURA IMMUNOGLOBULINS MARKET 2020–2026 ($ BILLION)
TABLE 97 GLOBAL IMMUNE THROMBOCYTOPENIC PURPURA IMMUNOGLOBULINS MARKET 2020–2026 (%)
TABLE 98 GLOBAL MYASTHENIA GRAVIS IMMUNOGLOBULINS MARKET 2020–2026 ($ BILLION)
TABLE 99 GLOBAL MYASTHENIA GRAVIS IMMUNOGLOBULINS MARKET 2020–2026 (%)
TABLE 100 GLOBAL IMMUNOGLOBULINS MARKET BY OTHERS 2020–2026 ($ BILLION)
TABLE 101 GLOBAL IMMUNOGLOBULINS MARKET BY OTHERS 2020–2026 (%)
TABLE 102 GLOBAL HOSPITALS & CLINICS IMMUNOGLOBULINS MARKET 2020–2026 ($ BILLION)
TABLE 103 GLOBAL HOSPITALS & CLINICS IMMUNOGLOBULINS MARKET 2020–2026 (%)
TABLE 104 GLOBAL HOMECARE IMMUNOGLOBULINS MARKET 2020–2026 ($ BILLION)
TABLE 105 GLOBAL HOMECARE IMMUNOGLOBULINS MARKET 2020–2026 (%)